chr1-156624697-G-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_021817.3(HAPLN2):​c.653G>A​(p.Arg218Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,595,798 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

HAPLN2
NM_021817.3 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.440
Variant links:
Genes affected
HAPLN2 (HGNC:17410): (hyaluronan and proteoglycan link protein 2) Predicted to enable hyaluronic acid binding activity. Predicted to be involved in central nervous system development and skeletal system development. Predicted to act upstream of or within establishment of blood-nerve barrier and extracellular matrix assembly. Predicted to be located in extracellular region. Predicted to be active in extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.026423842).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HAPLN2NM_021817.3 linkuse as main transcriptc.653G>A p.Arg218Gln missense_variant 6/7 ENST00000255039.6
HAPLN2XM_011509853.3 linkuse as main transcriptc.653G>A p.Arg218Gln missense_variant 6/7
HAPLN2XM_017002020.2 linkuse as main transcriptc.653G>A p.Arg218Gln missense_variant 7/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HAPLN2ENST00000255039.6 linkuse as main transcriptc.653G>A p.Arg218Gln missense_variant 6/71 NM_021817.3 P1
HAPLN2ENST00000494218.1 linkuse as main transcriptn.501G>A non_coding_transcript_exon_variant 2/32

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152214
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000144
AC:
30
AN:
207734
Hom.:
0
AF XY:
0.000164
AC XY:
19
AN XY:
115542
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000314
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000245
Gnomad FIN exome
AF:
0.000276
Gnomad NFE exome
AF:
0.000198
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000137
AC:
198
AN:
1443584
Hom.:
1
Cov.:
33
AF XY:
0.000139
AC XY:
100
AN XY:
717366
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000233
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000200
Gnomad4 FIN exome
AF:
0.000471
Gnomad4 NFE exome
AF:
0.000138
Gnomad4 OTH exome
AF:
0.0000838
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152214
Hom.:
0
Cov.:
32
AF XY:
0.000269
AC XY:
20
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000659
Gnomad4 NFE
AF:
0.000323
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000331
Hom.:
0
Bravo
AF:
0.000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000362
AC:
3
ExAC
AF:
0.000196
AC:
23

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 23, 2024The c.653G>A (p.R218Q) alteration is located in exon 6 (coding exon 4) of the HAPLN2 gene. This alteration results from a G to A substitution at nucleotide position 653, causing the arginine (R) at amino acid position 218 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.5
DANN
Benign
0.90
DEOGEN2
Benign
0.035
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.39
T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.026
T
MetaSVM
Benign
-0.93
T
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-0.41
N
REVEL
Benign
0.038
Sift
Benign
0.70
T
Sift4G
Benign
0.56
T
Polyphen
0.010
B
Vest4
0.078
MVP
0.16
MPC
0.97
ClinPred
0.012
T
GERP RS
-2.5
Varity_R
0.027
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs202081881; hg19: chr1-156594489; API